DNMT1 and systemic sclerosis: In summary, our study showed that ciprofloxacin has antifibrotic actions in SSc dermal and lung fibroblasts via downregulation of Dnmt1, upregulation of Fli1 and induction of MMP1 gene expression via an Erk1/2-dependent mechanism (Fig. 6).